Fig. 8. GSPRFFamide decreases the amplitude of EJPs. (A) Effects of
107 mol l1 GSPRFFamide. EJPs were evoked
by the stimulus train (1 ms, 1.6 V, 10 Hz) for 0.5 s every 20 s. (B)
Comparison of EJPs before (a) and after (b) GSPRFFamide application. (C)
Inhibitory action of GSPRFFamide on EJPs. Histogram shows mean ±
S.E. of the maximum amplitude of summated EJPs before and after
GSPRFFamide application (N=14). Statistical significance was assessed
by Student's t-test.